Digital Therapeutics (DTx) Development Expertise

Advancing Innovation in Digital Therapeutics

Creating Opportunity from Expertise

Digital health technologies are experiencing massive growth. Helping drive this surge are recent updates to regulatory guidance due to COVID-19 and increasing acceptance of decentralized medicine. This increased focus on digital therapeutic (DTx) development is helping to promote patient access to clinical care, facilitate the collection of real-world evidence, provide innovative alternatives to patients, and enhance the capabilities of personalized medicine. Premier Research has expertise in the design and execution of product development strategies for digital therapeutics. This knowledge is essential in a DTx environment characterized by rapidly changing regulatory stances and evolving payer policies that can leave sponsors with many unknowns. By combining our novel approaches to digital therapeutic development with our strength in psychiatric and neurological indications, our experts bring innovative strategies to advance your DTx development program.

Why choose Premier?

• End-to-end product development capabilities from early planning to execution to commercialization
• Unmatched in-house expertise in psychiatric and neurological indications
• FDA and EMA expertise for navigating the latest regulations
• Reimbursement and Go to Market strategies for your DTx
• Focused team experienced in conducting clinical studies supporting the decentralized model for DTx